Tru2u review

The referral structure is the essential fact to understand before comparing Tru2u with direct-care programs. A $225 or $345 card is not a verified monthly treatment rate; obtain the partner's exact product, first charge, renewal and refund agreement before proceeding.

Tru2u operates a storefront that includes supplements and advertises a route into prescription weight care. Its linked terms expressly say Tru2u is not a licensed healthcare provider, medical practice or pharmacy. They name independent CareValidate as the partner for telehealth consultations and prescriptions. A public Tru2U-branded clinic page offers a weight-loss consultation type; it does not identify the medical entity or clinician assigned to a patient.

Storefront merchandise and clinical services have different sellers and terms. The site describes an online health questionnaire and provider review, with a prescription only if clinically appropriate. It does not establish that every displayed GLP-1 product card is available to every consumer; product text also refers to qualified healthcare professionals.

The storefront describes an application, team review and purchase authorization. Its clinic landing page describes medical intake, review, a treatment plan and continuing support. The exact clinician, medical group, pharmacy, visit schedule, lab requirements and state eligibility are not identified in the public material.

Tru2u's product pages give short review and delivery estimates, but the retail shipping policy focuses on ordinary store goods. It does not establish prescription delivery charges, timing, handling or locations under CareValidate's clinical arrangement. Confirm those points with the clinical partner for the proposed treatment.

Tru2u displays $225 on compounded semaglutide injection and oral semaglutide cards, $345 on compounded tirzepatide injection and oral tirzepatide cards, and $275 on a combination card. These are displayed card amounts without an established treatment period, dose, quantity or complete clinical cost. Do not convert them into monthly plan prices or a universal entry charge.

The pages do not settle the first debit, consultation fee, renewal interval, dose-dependent price or amount due after clinical approval. General store terms allow some recurring products but do not establish that a particular GLP-1 card renews or that they govern CareValidate's billing. Ask for the exact prescription and an itemized initial and ongoing charge from the party taking payment.

The storefront's seven-day return policy concerns eligible unopened retail goods. It does not establish refund rights for a prescription or a clinical visit. The product FAQ mentions changing a treatment through a portal or care team, while the linked terms put clinical care under partner policies. Obtain the applicable cancellation deadline, refund cutoff and renewal authorization before payment. Insurance benefit eligibility is described as variable; the storefront primarily describes cash-pay access.

The store lists compounded semaglutide and tirzepatide injections and oral tablets, plus a combination card. It does not disclose exact formulations, strengths, supply, additives or the dispensing pharmacy, and individual consumer availability is unresolved. Product FAQs broadly call treatments FDA-approved, while the site's compounding disclaimer says compounded drugs are not FDA-approved. The broad approval claim should not be applied to these cards; ask the prescriber for the actual product and its regulatory status.